• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于核磁共振的新方法揭示癌细胞中细胞毒性金药物的“代谢指纹”

Novel NMR-Based Approach to Reveal the 'Metabolic Fingerprint' of Cytotoxic Gold Drugs in Cancer Cells.

作者信息

Ghini Veronica, Tristán Ana Isabel, Di Paco Giorgio, Massai Lara, Mannelli Michele, Gamberi Tania, Fernández Ignacio, Rosato Antonio, Turano Paola, Messori Luigi

机构信息

Department of Chemistry "Ugo Schiff", University of Florence, Sesto Fiorentino 50019, Italy.

Department of Chemistry and Physics, Research Centre CIAIMBITAL, University of Almería, Ctra. Sacramento, s/n, Almeria 04120, Spain.

出版信息

J Proteome Res. 2025 Feb 7;24(2):813-823. doi: 10.1021/acs.jproteome.4c00904. Epub 2025 Jan 6.

DOI:10.1021/acs.jproteome.4c00904
PMID:39757834
Abstract

A combination of pathway enrichment and metabolite clustering analysis is used to interpret untargeted H NMR metabolomics data, enabling a biochemically informative comparison of the effects induced by a panel of known cytotoxic gold(I) and gold(III) compounds in A2780 ovarian cancer cells. The identification of the most dysregulated pathways for the major classes of compounds highlights specific chemical features that lead to common biological effects. The proposed approach may have broader applicability to the screening of metal-based drug candidate libraries, which is always complicated by their multitarget nature, and support the comprehensive interpretation of their metabolic actions.

摘要

采用通路富集和代谢物聚类分析相结合的方法来解释非靶向氢核磁共振代谢组学数据,从而能够对一组已知的细胞毒性金(I)和金(III)化合物在A2780卵巢癌细胞中诱导的效应进行具有生物化学信息的比较。对主要类别化合物中失调最严重的通路进行鉴定,突出了导致共同生物学效应的特定化学特征。所提出的方法可能在基于金属的药物候选库筛选中具有更广泛的适用性,这类筛选总是因其多靶点性质而变得复杂,该方法还支持对其代谢作用进行全面解释。

相似文献

1
Novel NMR-Based Approach to Reveal the 'Metabolic Fingerprint' of Cytotoxic Gold Drugs in Cancer Cells.基于核磁共振的新方法揭示癌细胞中细胞毒性金药物的“代谢指纹”
J Proteome Res. 2025 Feb 7;24(2):813-823. doi: 10.1021/acs.jproteome.4c00904. Epub 2025 Jan 6.
2
NMR Metabolomics of Primary Ovarian Cancer Cells in Comparison to Established Cisplatin-Resistant and -Sensitive Cell Lines.原发性卵巢癌细胞的 NMR 代谢组学与已建立的顺铂耐药和敏感细胞系的比较。
Cells. 2024 Apr 9;13(8):661. doi: 10.3390/cells13080661.
3
Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipy(c).A2780/S卵巢癌细胞对细胞毒性有机金(III)化合物Aubipy(c)反应的蛋白质组学分析
J Proteomics. 2014 May 30;103:103-20. doi: 10.1016/j.jprot.2014.03.032. Epub 2014 Apr 3.
4
Proteomic analysis of the cytotoxic effects induced by the organogold(III) complex Aubipyc in cisplatin-resistant A2780 ovarian cancer cells: further evidence for the glycolytic pathway implication.有机金(III)配合物Aubipyc对顺铂耐药的A2780卵巢癌细胞诱导的细胞毒性作用的蛋白质组学分析:糖酵解途径参与的进一步证据
Mol Biosyst. 2015 Jun;11(6):1653-67. doi: 10.1039/c5mb00008d.
5
Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties.抗癌环金属化[Au(III)m(C(楔)N(楔)C)mL]n+化合物:合成与细胞毒性特性
Chemistry. 2006 Jul 5;12(20):5253-66. doi: 10.1002/chem.200600117.
6
Mechanisms of cytotoxicity of selected organogold(III) compounds.所选有机金(III)化合物的细胞毒性机制。
J Med Chem. 2005 Oct 20;48(21):6761-5. doi: 10.1021/jm050493o.
7
NMR-Based Metabolomics in Metal-Based Drug Research.基于 NMR 的金属药物研究中的代谢组学。
Molecules. 2019 Jun 15;24(12):2240. doi: 10.3390/molecules24122240.
8
Synthesis, structural characterization, solution behavior, and in vitro antiproliferative properties of a series of gold complexes with 2-(2'-pyridyl)benzimidazole as ligand: comparisons of gold(III) versus gold(I) and mononuclear versus binuclear derivatives.一系列以 2-(2'-吡啶基)苯并咪唑为配体的金配合物的合成、结构表征、溶液行为及体外抗增殖活性:金(III)与金(I)和单核与双核衍生物的比较。
Inorg Chem. 2012 Mar 5;51(5):3161-71. doi: 10.1021/ic202639t. Epub 2012 Feb 17.
9
The synthesis, chemical and biological properties of dichlorido(azpy)gold(III) chloride (azpy=2-(phenylazo)pyridine) and the gold-induced conversion of the azpy ligand to the chloride of the novel tricyclic pyrido[2,1-c][1,2,4]benzotriazin-11-ium cation.二氯(偶氮吡啶)金(III)氯化物(偶氮吡啶 = 2-(苯基偶氮)吡啶)的合成、化学和生物学性质以及金诱导的偶氮吡啶配体向新型三环吡啶并[2,1-c][1,2,4]苯并三嗪-11-鎓阳离子的氯的转化。
J Inorg Biochem. 2007 Nov;101(11-12):1922-30. doi: 10.1016/j.jinorgbio.2007.05.008. Epub 2007 Jun 2.
10
Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: solution behavior, reactions with model proteins, antiproliferative properties.含 2-取代吡啶的金(III)配合物作为实验性抗癌剂:溶液行为、与模型蛋白的反应、抗增殖特性。
J Inorg Biochem. 2012 Mar;108:123-7. doi: 10.1016/j.jinorgbio.2011.11.007. Epub 2011 Nov 22.

引用本文的文献

1
Modeling the metabolic response of A2780 ovarian cancer cells to gold-based cytotoxic drugs.模拟A2780卵巢癌细胞对金基细胞毒性药物的代谢反应。
NPJ Syst Biol Appl. 2025 Jul 28;11(1):83. doi: 10.1038/s41540-025-00535-9.